Trial intelligence / Profile preview

Multimodal treatment effects on empathy in adolescents with ADHD

NL-OMON43931Active, not recruiting

Sponsor
Utrecht University
Start
Jun 2015
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of methylphenidate in attention deficit hyperactivity disorder (ADHD) and Disruptive behavior disorders (DBD), sponsored by Utrecht University. Primary endpoints: Trait empathy, State empathy and 2 more. Started Jun 2015; status: active, not recruiting.

02

Drugs

methylphenidate
03

Conditions

attention deficit hyperactivity disorder (ADHD)Disruptive behavior disorders (DBD)

Beyond the preview

Go deeper on NL-OMON43931.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON43931.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call